Global Cellular and Gene Therapy Product Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Report ID: GIR2209280001 | Category: Service & Software | Pages: 124 | Format: PDF | Published Date: October 21,2022

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

According to our (Global Info Research) latest study, the global Cellular and Gene Therapy Product market size was valued at USD million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Cellular and Gene Therapy Product market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2022, are provided.
Key Features:
Global Cellular and Gene Therapy Product market size and forecasts, in consumption value ($ Million), 2017-2028
Global Cellular and Gene Therapy Product market size and forecasts by region and country, in consumption value ($ Million), 2017-2028
Global Cellular and Gene Therapy Product market size and forecasts, by Type and by Application, in consumption value ($ Million), 2017-2028
Global Cellular and Gene Therapy Product market shares of main players, in revenue ($ Million), 2017-2022
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cellular and Gene Therapy Product
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cellular and Gene Therapy Product market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bristol-Myers Squibb, New York Blood Center, Johnson & Johnson, Cleveland Cord Blood Center and Organogenesis, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Cellular and Gene Therapy Product market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
    Cellular Immunotherapies
    Cancer Vaccines
    Autologous and Allogeneic Cells
Market segment by Application
    Blood Cancer
    Prostate Cancer
    Skin Cancer
    Other
Market segment by players, this report covers
    Bristol-Myers Squibb
    New York Blood Center
    Johnson & Johnson
    Cleveland Cord Blood Center
    Organogenesis
    Duke University School of Medicine
    Colorado Cord Blood Banking
    MD Anderson Cancer Center
    LifeSouth Community Blood Centers
    Bloodworks Northwest
    Amgen
    Novartis Pharmaceuticals
    Castle Creek Biosciences
    Spark Therapeutics
    Vericel
    Dendreon Pharmaceuticals
    Enzyvant Therapeutics GmbH
    Mallinckrodt
    Gilead Sciences
    bluebird bio
Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cellular and Gene Therapy Product product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cellular and Gene Therapy Product, with revenue, gross margin and global market share of Cellular and Gene Therapy Product from 2017 to 2022.
Chapter 3, the Cellular and Gene Therapy Product competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Cellular and Gene Therapy Product market forecast, by regions, type and application, with consumption value, from 2023 to 2028.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Cellular and Gene Therapy Product.
Chapter 13, to describe Cellular and Gene Therapy Product research findings and conclusion.

1 Market Overview
    1.1 Product Overview and Scope of Cellular and Gene Therapy Product
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Cellular and Gene Therapy Product by Type
        1.3.1 Overview: Global Cellular and Gene Therapy Product Market Size by Type: 2017 Versus 2021 Versus 2028
        1.3.2 Global Cellular and Gene Therapy Product Consumption Value Market Share by Type in 2021
        1.3.3 Cellular Immunotherapies
        1.3.4 Cancer Vaccines
        1.3.5 Autologous and Allogeneic Cells
    1.4 Global Cellular and Gene Therapy Product Market by Application
        1.4.1 Overview: Global Cellular and Gene Therapy Product Market Size by Application: 2017 Versus 2021 Versus 2028
        1.4.2 Blood Cancer
        1.4.3 Prostate Cancer
        1.4.4 Skin Cancer
        1.4.5 Other
    1.5 Global Cellular and Gene Therapy Product Market Size & Forecast
    1.6 Global Cellular and Gene Therapy Product Market Size and Forecast by Region
        1.6.1 Global Cellular and Gene Therapy Product Market Size by Region: 2017 VS 2021 VS 2028
        1.6.2 Global Cellular and Gene Therapy Product Market Size by Region, (2017-2028)
        1.6.3 North America Cellular and Gene Therapy Product Market Size and Prospect (2017-2028)
        1.6.4 Europe Cellular and Gene Therapy Product Market Size and Prospect (2017-2028)
        1.6.5 Asia-Pacific Cellular and Gene Therapy Product Market Size and Prospect (2017-2028)
        1.6.6 South America Cellular and Gene Therapy Product Market Size and Prospect (2017-2028)
        1.6.7 Middle East and Africa Cellular and Gene Therapy Product Market Size and Prospect (2017-2028)
2 Company Profiles
    2.1 Bristol-Myers Squibb
        2.1.1 Bristol-Myers Squibb Details
        2.1.2 Bristol-Myers Squibb Major Business
        2.1.3 Bristol-Myers Squibb Cellular and Gene Therapy Product Product and Solutions
        2.1.4 Bristol-Myers Squibb Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
        2.1.5 Bristol-Myers Squibb Recent Developments and Future Plans
    2.2 New York Blood Center
        2.2.1 New York Blood Center Details
        2.2.2 New York Blood Center Major Business
        2.2.3 New York Blood Center Cellular and Gene Therapy Product Product and Solutions
        2.2.4 New York Blood Center Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
        2.2.5 New York Blood Center Recent Developments and Future Plans
    2.3 Johnson & Johnson
        2.3.1 Johnson & Johnson Details
        2.3.2 Johnson & Johnson Major Business
        2.3.3 Johnson & Johnson Cellular and Gene Therapy Product Product and Solutions
        2.3.4 Johnson & Johnson Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
        2.3.5 Johnson & Johnson Recent Developments and Future Plans
    2.4 Cleveland Cord Blood Center
        2.4.1 Cleveland Cord Blood Center Details
        2.4.2 Cleveland Cord Blood Center Major Business
        2.4.3 Cleveland Cord Blood Center Cellular and Gene Therapy Product Product and Solutions
        2.4.4 Cleveland Cord Blood Center Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
        2.4.5 Cleveland Cord Blood Center Recent Developments and Future Plans
    2.5 Organogenesis
        2.5.1 Organogenesis Details
        2.5.2 Organogenesis Major Business
        2.5.3 Organogenesis Cellular and Gene Therapy Product Product and Solutions
        2.5.4 Organogenesis Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
        2.5.5 Organogenesis Recent Developments and Future Plans
    2.6 Duke University School of Medicine
        2.6.1 Duke University School of Medicine Details
        2.6.2 Duke University School of Medicine Major Business
        2.6.3 Duke University School of Medicine Cellular and Gene Therapy Product Product and Solutions
        2.6.4 Duke University School of Medicine Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
        2.6.5 Duke University School of Medicine Recent Developments and Future Plans
    2.7 Colorado Cord Blood Banking
        2.7.1 Colorado Cord Blood Banking Details
        2.7.2 Colorado Cord Blood Banking Major Business
        2.7.3 Colorado Cord Blood Banking Cellular and Gene Therapy Product Product and Solutions
        2.7.4 Colorado Cord Blood Banking Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
        2.7.5 Colorado Cord Blood Banking Recent Developments and Future Plans
    2.8 MD Anderson Cancer Center
        2.8.1 MD Anderson Cancer Center Details
        2.8.2 MD Anderson Cancer Center Major Business
        2.8.3 MD Anderson Cancer Center Cellular and Gene Therapy Product Product and Solutions
        2.8.4 MD Anderson Cancer Center Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
        2.8.5 MD Anderson Cancer Center Recent Developments and Future Plans
    2.9 LifeSouth Community Blood Centers
        2.9.1 LifeSouth Community Blood Centers Details
        2.9.2 LifeSouth Community Blood Centers Major Business
        2.9.3 LifeSouth Community Blood Centers Cellular and Gene Therapy Product Product and Solutions
        2.9.4 LifeSouth Community Blood Centers Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
        2.9.5 LifeSouth Community Blood Centers Recent Developments and Future Plans
    2.10 Bloodworks Northwest 
        2.10.1 Bloodworks Northwest Details
        2.10.2 Bloodworks Northwest Major Business
        2.10.3 Bloodworks Northwest Cellular and Gene Therapy Product Product and Solutions
        2.10.4 Bloodworks Northwest Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
        2.10.5 Bloodworks Northwest Recent Developments and Future Plans
    2.11 Amgen
        2.11.1 Amgen Details
        2.11.2 Amgen Major Business
        2.11.3 Amgen Cellular and Gene Therapy Product Product and Solutions
        2.11.4 Amgen Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
        2.11.5 Amgen Recent Developments and Future Plans
    2.12 Novartis Pharmaceuticals
        2.12.1 Novartis Pharmaceuticals Details
        2.12.2 Novartis Pharmaceuticals Major Business
        2.12.3 Novartis Pharmaceuticals Cellular and Gene Therapy Product Product and Solutions
        2.12.4 Novartis Pharmaceuticals Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
        2.12.5 Novartis Pharmaceuticals Recent Developments and Future Plans
    2.13 Castle Creek Biosciences
        2.13.1 Castle Creek Biosciences Details
        2.13.2 Castle Creek Biosciences Major Business
        2.13.3 Castle Creek Biosciences Cellular and Gene Therapy Product Product and Solutions
        2.13.4 Castle Creek Biosciences Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
        2.13.5 Castle Creek Biosciences Recent Developments and Future Plans
    2.14 Spark Therapeutics
        2.14.1 Spark Therapeutics Details
        2.14.2 Spark Therapeutics Major Business
        2.14.3 Spark Therapeutics Cellular and Gene Therapy Product Product and Solutions
        2.14.4 Spark Therapeutics Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
        2.14.5 Spark Therapeutics Recent Developments and Future Plans
    2.15 Vericel
        2.15.1 Vericel Details
        2.15.2 Vericel Major Business
        2.15.3 Vericel Cellular and Gene Therapy Product Product and Solutions
        2.15.4 Vericel Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
        2.15.5 Vericel Recent Developments and Future Plans
    2.16 Dendreon Pharmaceuticals
        2.16.1 Dendreon Pharmaceuticals Details
        2.16.2 Dendreon Pharmaceuticals Major Business
        2.16.3 Dendreon Pharmaceuticals Cellular and Gene Therapy Product Product and Solutions
        2.16.4 Dendreon Pharmaceuticals Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
        2.16.5 Dendreon Pharmaceuticals Recent Developments and Future Plans
    2.17 Enzyvant Therapeutics GmbH
        2.17.1 Enzyvant Therapeutics GmbH Details
        2.17.2 Enzyvant Therapeutics GmbH Major Business
        2.17.3 Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Product and Solutions
        2.17.4 Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
        2.17.5 Enzyvant Therapeutics GmbH Recent Developments and Future Plans
    2.18 Mallinckrodt
        2.18.1 Mallinckrodt Details
        2.18.2 Mallinckrodt Major Business
        2.18.3 Mallinckrodt Cellular and Gene Therapy Product Product and Solutions
        2.18.4 Mallinckrodt Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
        2.18.5 Mallinckrodt Recent Developments and Future Plans
    2.19 Gilead Sciences
        2.19.1 Gilead Sciences Details
        2.19.2 Gilead Sciences Major Business
        2.19.3 Gilead Sciences Cellular and Gene Therapy Product Product and Solutions
        2.19.4 Gilead Sciences Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
        2.19.5 Gilead Sciences Recent Developments and Future Plans
    2.20 bluebird bio
        2.20.1 bluebird bio Details
        2.20.2 bluebird bio Major Business
        2.20.3 bluebird bio Cellular and Gene Therapy Product Product and Solutions
        2.20.4 bluebird bio Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
        2.20.5 bluebird bio Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Cellular and Gene Therapy Product Revenue and Share by Players (2017-2022)
    3.2 Market Share Analysis (2021)
        3.2.1 Market Share of Cellular and Gene Therapy Product by Company Revenue
        3.2.2 Top 3 Cellular and Gene Therapy Product Players Market Share in 2021
        3.2.3 Top 6 Cellular and Gene Therapy Product Players Market Share in 2021
    3.3 Cellular and Gene Therapy Product Market: Overall Company Footprint Analysis
        3.3.1 Cellular and Gene Therapy Product Market: Region Footprint
        3.3.2 Cellular and Gene Therapy Product Market: Company Product Type Footprint
        3.3.3 Cellular and Gene Therapy Product Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
    4.1 Global Cellular and Gene Therapy Product Consumption Value and Market Share by Type (2017-2022)
    4.2 Global Cellular and Gene Therapy Product Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
    5.1 Global Cellular and Gene Therapy Product Consumption Value Market Share by Application (2017-2022)
    5.2 Global Cellular and Gene Therapy Product Market Forecast by Application (2023-2028)
6 North America
    6.1 North America Cellular and Gene Therapy Product Consumption Value by Type (2017-2028)
    6.2 North America Cellular and Gene Therapy Product Consumption Value by Application (2017-2028)
    6.3 North America Cellular and Gene Therapy Product Market Size by Country
        6.3.1 North America Cellular and Gene Therapy Product Consumption Value by Country (2017-2028)
        6.3.2 United States Cellular and Gene Therapy Product Market Size and Forecast (2017-2028)
        6.3.3 Canada Cellular and Gene Therapy Product Market Size and Forecast (2017-2028)
        6.3.4 Mexico Cellular and Gene Therapy Product Market Size and Forecast (2017-2028)
7 Europe
    7.1 Europe Cellular and Gene Therapy Product Consumption Value by Type (2017-2028)
    7.2 Europe Cellular and Gene Therapy Product Consumption Value by Application (2017-2028)
    7.3 Europe Cellular and Gene Therapy Product Market Size by Country
        7.3.1 Europe Cellular and Gene Therapy Product Consumption Value by Country (2017-2028)
        7.3.2 Germany Cellular and Gene Therapy Product Market Size and Forecast (2017-2028)
        7.3.3 France Cellular and Gene Therapy Product Market Size and Forecast (2017-2028)
        7.3.4 United Kingdom Cellular and Gene Therapy Product Market Size and Forecast (2017-2028)
        7.3.5 Russia Cellular and Gene Therapy Product Market Size and Forecast (2017-2028)
        7.3.6 Italy Cellular and Gene Therapy Product Market Size and Forecast (2017-2028)
8 Asia-Pacific
    8.1 Asia-Pacific Cellular and Gene Therapy Product Consumption Value by Type (2017-2028)
    8.2 Asia-Pacific Cellular and Gene Therapy Product Consumption Value by Application (2017-2028)
    8.3 Asia-Pacific Cellular and Gene Therapy Product Market Size by Region
        8.3.1 Asia-Pacific Cellular and Gene Therapy Product Consumption Value by Region (2017-2028)
        8.3.2 China Cellular and Gene Therapy Product Market Size and Forecast (2017-2028)
        8.3.3 Japan Cellular and Gene Therapy Product Market Size and Forecast (2017-2028)
        8.3.4 South Korea Cellular and Gene Therapy Product Market Size and Forecast (2017-2028)
        8.3.5 India Cellular and Gene Therapy Product Market Size and Forecast (2017-2028)
        8.3.6 Southeast Asia Cellular and Gene Therapy Product Market Size and Forecast (2017-2028)
        8.3.7 Australia Cellular and Gene Therapy Product Market Size and Forecast (2017-2028)
9 South America
    9.1 South America Cellular and Gene Therapy Product Consumption Value by Type (2017-2028)
    9.2 South America Cellular and Gene Therapy Product Consumption Value by Application (2017-2028)
    9.3 South America Cellular and Gene Therapy Product Market Size by Country
        9.3.1 South America Cellular and Gene Therapy Product Consumption Value by Country (2017-2028)
        9.3.2 Brazil Cellular and Gene Therapy Product Market Size and Forecast (2017-2028)
        9.3.3 Argentina Cellular and Gene Therapy Product Market Size and Forecast (2017-2028)
10 Middle East & Africa
    10.1 Middle East & Africa Cellular and Gene Therapy Product Consumption Value by Type (2017-2028)
    10.2 Middle East & Africa Cellular and Gene Therapy Product Consumption Value by Application (2017-2028)
    10.3 Middle East & Africa Cellular and Gene Therapy Product Market Size by Country
        10.3.1 Middle East & Africa Cellular and Gene Therapy Product Consumption Value by Country (2017-2028)
        10.3.2 Turkey Cellular and Gene Therapy Product Market Size and Forecast (2017-2028)
        10.3.3 Saudi Arabia Cellular and Gene Therapy Product Market Size and Forecast (2017-2028)
        10.3.4 UAE Cellular and Gene Therapy Product Market Size and Forecast (2017-2028)
11 Market Dynamics
    11.1 Cellular and Gene Therapy Product Market Drivers
    11.2 Cellular and Gene Therapy Product Market Restraints
    11.3 Cellular and Gene Therapy Product Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War
12 Upstream and Industry Chain
    12.1 Raw Material of Cellular and Gene Therapy Product and Key Suppliers
    12.2 Manufacturing Costs Percentage of Cellular and Gene Therapy Product
    12.3 Cellular and Gene Therapy Product Production Process
    12.4 Industry Value Chain Analysis
13 Research Findings and Conclusion
14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Cellular and Gene Therapy Product Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?